Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MACROGENICS INC Director's Dealing 2026

Feb 10, 2026

34129_dirs_2026-02-10_aad17764-d029-4285-b8cd-3c3853afefbd.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2026-02-07

Reporting Person: Peters Jeffrey Stuart (Senior VP, GC, and Secretary)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2026-02-07 Common Stock M 6001 Acquired 19712 Direct
2026-02-07 Common Stock F 2317 $1.81 Disposed 17395 Direct
2026-02-08 Common Stock M 8999 Acquired 26394 Direct
2026-02-08 Common Stock F 3474 $1.81 Disposed 22920 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2026-02-07 Restricted Stock Unit $ M 6001 Disposed Common Stock (6001) Direct
2026-02-08 Restricted Stock Unit $ M 8999 Disposed Common Stock (8999) Direct

Footnotes

F1: Restricted stock units convert into the Company's stock on a one-for-one basis.

F2: On February 7, 2025, the reporting person was granted 18,000 restricted stock units, vesting in three equal installments beginning on the first anniversary of the grant date

F3: On February 8, 2024, the reporting person was granted 27,000 restricted stock units, vesting in three equal installments beginning on the first anniversary of the grant date.